Ronald R Blanck - Net Worth and Insider Trading

Ronald R Blanck Net Worth

The estimated net worth of Ronald R Blanck is at least $24 dollars as of 2024-12-15. Ronald R Blanck is the Director of Tenax Therapeutics Inc and owns about 4 shares of Tenax Therapeutics Inc (TENX) stock worth over $24. Details can be seen in Ronald R Blanck's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ronald R Blanck has not made any transactions after 2020-05-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Ronald R Blanck

To

Ronald R Blanck Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ronald R Blanck owns 1 companies in total, including Tenax Therapeutics Inc (TENX) .

Click here to see the complete history of Ronald R Blanck’s form 4 insider trades.

Insider Ownership Summary of Ronald R Blanck

Ticker Comapny Transaction Date Type of Owner
TENX Tenax Therapeutics Inc 2020-05-18 director

Ronald R Blanck Latest Holdings Summary

Ronald R Blanck currently owns a total of 1 stock. Ronald R Blanck owns 4 shares of Tenax Therapeutics Inc (TENX) as of May 18, 2020, with a value of $24.

Latest Holdings of Ronald R Blanck

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TENX Tenax Therapeutics Inc 2020-05-18 4 5.88 24

Holding Weightings of Ronald R Blanck


Ronald R Blanck Form 4 Trading Tracker

According to the SEC Form 4 filings, Ronald R Blanck has made a total of 1 transactions in Tenax Therapeutics Inc (TENX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tenax Therapeutics Inc is the acquisition of 3 shares on May 18, 2020, which cost Ronald R Blanck around $4,750.

Insider Trading History of Ronald R Blanck

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ronald R Blanck Trading Performance

GuruFocus tracks the stock performance after each of Ronald R Blanck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ronald R Blanck is -9.05%. GuruFocus also compares Ronald R Blanck's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ronald R Blanck within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ronald R Blanck's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ronald R Blanck

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.99 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -4.54 LIMIT LIMIT LIMIT LIMIT LIMIT

Ronald R Blanck Ownership Network

Ownership Network List of Ronald R Blanck

No Data

Ownership Network Relation of Ronald R Blanck

Insider Network Chart

Ronald R Blanck Owned Company Details

What does Tenax Therapeutics Inc do?

Who are the key executives at Tenax Therapeutics Inc?

Ronald R Blanck is the director of Tenax Therapeutics Inc. Other key executives at Tenax Therapeutics Inc include Interim CFO Eliot M Lurier , director & CEO Chrisopher Thomas Giordano , and Chief Medical Officer Stuart Rich .

Tenax Therapeutics Inc (TENX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tenax Therapeutics Inc (TENX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tenax Therapeutics Inc (TENX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tenax Therapeutics Inc (TENX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tenax Therapeutics Inc Insider Transactions

No Available Data

Ronald R Blanck Mailing Address

Above is the net worth, insider trading, and ownership report for Ronald R Blanck. You might contact Ronald R Blanck via mailing address: 2001 Walnut Hill Lane, Irving Tx 75038.